Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Nov 1 2021

Full Issue

Final CDC Decision On Pfizer Vaccine For Younger Kids Expected This Week

It would be the last hurdle before children ages 5 to 11 could start receiving the covid shot, after the Food and Drug Administration signed off Friday. Because of the smaller doses, logistics for this rollout will be more complex than for adults. So the White House is warning parents that it may take time.

The New York Times: FDA Clears Pfizer Coronavirus Vaccine For Young Children 

The Food and Drug Administration on Friday authorized Pfizer-BioNTech’s coronavirus vaccine for emergency use in children 5 to 11, a move eagerly anticipated by millions of families looking to protect some of the only remaining Americans left out of the vaccination campaign. About 28 million children in the group will be eligible to receive one-third of the adult dose, with two injections three weeks apart. If the Centers for Disease Control and Prevention signs off, as is expected, they could start getting shots as early as Wednesday. (Weiland and LaFraniere, 10/29)

Stat: FDA Authorizes Pfizer Covid-19 Vaccine For Children Aged 5 To 11 

The Pfizer-BioNTech Covid vaccine for children 5 to 11 should be given as two doses three weeks apart, just like the version for older children and adults, but uses a lower 10-microgram dose, one-third the adult dose. (Herper, 10/29)

In related news —

Houston Chronicle: Texas Children's Taking Appointments For Kids' COVID Vaccines With Emergency Authorization Imminent

Texas Children’s Hospital is now scheduling appointments to administer a Pfizer COVID-19 shot for children ages 5 to 11 years old, in anticipation of federal health agencies giving emergency authorization next week. Right now, appointments for Nov. 6 through Nov. 20 at campuses across the Houston area can be scheduled on the hospital’s website. Additional appointments also will be offered within 24 hours of emergency use authorization, which is expected to be finalized Tuesday, said Jermaine Monroe, co-chair of the Texas Children’s Hospital COVID vaccine task force. After the Food and Drug Administration issues the emergency use authorization, a Centers for Disease Control and Prevention advisory panel will meet to discuss any possible restrictions for the shot. The vaccine can be administered once CDC Director Rochelle Walensky signs off on the authorization. (Gill, 10/29)

NPR: Parents Should Be Patient About Getting COVID Vaccines For Kids

Within minutes of the Food and Drug Administration's decision Friday to authorize the lower-dose Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, teams began packing up the vaccines to be shipped. The vials are being packed with syringes, dry ice and tracking labels and are being loaded into shipping containers that were specially designed for the pediatric vaccine. But a top White House official is cautioning that parents shouldn't expect to be able to get their kids vaccinated the very next day if the Centers for Disease Control and Prevention recommends the vaccine, as it is expected to on Tuesday. Patience may be needed, as it could take several days before shots are readily available. (Keith, 10/30)

AP: Arizona Doctors Emphasize COVID-19 Vaccine Is Safe For Kids

The COVID-19 vaccine is safe for children and presents the best way to get past the inconveniences brought by the pandemic, Arizona doctors said as they look to reassure parents ahead of anticipated approval by the federal government. While most children who contract COVID-19 get only minor symptoms, doctors said some experience major complications, and the risk of severe disease is higher than the remote risk of serious vaccine side effects. With billions of doses of COVID-19 vaccines administered globally and extensive clinical trials in young people in the United States, the vaccine’s safety is clear, the doctors said. (Cooper, 10/31)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF